Crescent Capital BDC may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Crescent Capital's Capital Surpluse is relatively stable compared to the past year. As of 03/23/2025, Other Liabilities is likely to grow to about 1.2 M, while Total Stockholder Equity is likely to drop slightly above 478.8 M. Key indicators impacting Crescent Capital's financial strength include:
Investors should never underestimate Crescent Capital's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Crescent Capital's cash flow, debt, and profitability to make informed and accurate decisions about investing in Crescent Capital BDC.
Net Income
40.41 Million
Crescent
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Average Inventory
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change In Cash
Net Borrowings
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Other Non Cash Items
Dividends Paid
Total Cash From Operating Activities
Change To Account Receivables
Change To Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Netincome
Change To Liabilities
Depreciation
Stock Based Compensation
Issuance Of Capital Stock
Change To Inventory
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Tangible Assets
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Long Term Debt
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Common Stock Shares Outstanding
Long Term Debt Total
Liabilities And Stockholders Equity
Non Current Liabilities Total
Capital Surpluse
Other Stockholder Equity
Total Liab
Long Term Investments
Total Current Assets
Common Stock
Other Liab
Short Term Investments
Net Invested Capital
Other Current Assets
Capital Stock
Property Plant And Equipment Net
Current Deferred Revenue
Good Will
Inventory
Short Term Debt
Tax Provision
Interest Income
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income Applicable To Common Shares
Income Tax Expense
Net Interest Income
Depreciation And Amortization
Research Development
Probability Of Bankruptcy
Understanding current and past Crescent Capital Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Crescent Capital's financial statements are interrelated, with each one affecting the others. For example, an increase in Crescent Capital's assets may result in an increase in income on the income statement.
Crescent Capital competes with BlackRock TCP, Triplepoint Venture, Sixth Street, Golub Capital, and New Mountain. Crescent Capital BDC, Inc. is as a business development company private equity buyouts and loan fund. Crescent Capital operates under Asset Management classification in the United States and is traded on NASDAQ Exchange.
The reason investors look at the income statement is to determine what Crescent Capital's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Crescent Capital's current stock value. Our valuation model uses many indicators to compare Crescent Capital value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Crescent Capital competition to find correlations between indicators driving Crescent Capital's intrinsic value. More Info.
Crescent Capital BDC is rated fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Crescent Capital BDC is roughly 1.70 . At this time, Crescent Capital's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Crescent Capital by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Crescent Capital BDC Systematic Risk
Crescent Capital's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Crescent Capital volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Crescent Capital BDC correlated with the market. If Beta is less than 0 Crescent Capital generally moves in the opposite direction as compared to the market. If Crescent Capital Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Crescent Capital BDC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Crescent Capital is generally in the same direction as the market. If Beta > 1 Crescent Capital moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Crescent Capital Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Crescent Capital's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Crescent Capital growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Crescent Capital help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Crescent Capital BDC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Crescent Capital BDC based on widely used predictive technical indicators. In general, we focus on analyzing Crescent Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Crescent Capital's daily price indicators and compare them against related drivers.
When running Crescent Capital's price analysis, check to measure Crescent Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescent Capital is operating at the current time. Most of Crescent Capital's value examination focuses on studying past and present price action to predict the probability of Crescent Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescent Capital's price. Additionally, you may evaluate how the addition of Crescent Capital to your portfolios can decrease your overall portfolio volatility.